Comparative evaluation of three commercially available methodologies for hepatitis C virus genotyping

Area of Science:

• Virology
• Molecular Diagnostics
• Public Health

Background:

• Hepatitis C virus (HCV) infection is a significant global health concern.
• Accurate HCV genotyping is crucial for effective treatment selection and epidemiological studies.

Purpose of the Study:

• To compare the performance of three commercially available HCV genotyping methodologies.
• To evaluate the accuracy and reliability of Bayer, Abbott, and Third Wave Technologies assays.

Main Methods:

• Performance evaluation of three HCV genotyping assays: Bayer, Abbott, and Third Wave Technologies Invader assay.
• Genotyping was performed on 137 patient specimens.
• Comparison of genotype determination success rates and concordance.

Main Results:

• The Bayer method successfully genotyped 136 of 137 specimens.
• The Third Wave Technologies Invader assay genotyped 121 of 137 specimens.
• The Abbott assay had a lower success rate, genotyped 77 of 137 specimens.
• All genotypes reported by the three methods were concordant.

Conclusions:

• The Bayer and Third Wave Technologies assays demonstrate robust performance for hepatitis C virus genotyping.
• While the Abbott assay showed a lower success rate, concordance among the methods suggests reliability in reported genotypes.
• Further investigation may be warranted to optimize the Abbott assay's performance.